CEDRA Corp.

Anthony G. Busa, Jr., has been named chief executive officer of CEDRA Corp., a division of Worldwide Clinical Trials (WCT) and a provider of Phase I clinical research and bioanalytical services.

Mr. Busa has more than 34 years of experience in management positions including senior level management, regional and national sales and product development within the pharmaceutical and medical device industries. Previously, he held senior management related positions at McClintic Busa Group, LLP, dgd Research, Inc., Esoterix, Inc., Medsites, Inc., and Covance, Inc.

“Anthony is an experienced, high caliber professional. He has a thorough understanding of how this business and industry functions,” said Worldwide Clinical Trials chief operating officer, Tom Wardle. “He will be a great asset to our team in terms of growth and management.”